Riskpilot← Back to searchSign inGet full accessSan Serum AB
ABActiveOrg 5590707971Lillgatan 14Computer consultancy and computer facilities management activities · NACE 6220Est. 20160 employees
Revenue 2024
SEK 2,1M
+1% vs 2023
EBITDA margin
20.6%
-32% vs 2023
Equity ratio
79.5%
Financial strength
Net profit 2024
SEK 345K
-32% vs 2023
| Revenue | SEK 2,1M | +1% |
| EBITDA | SEK 439K | -32% |
| Net profit | SEK 345K | -32% |
| Total assets | SEK 2,8M | +12% |
| Equity | SEK 2,2M | +0% |
| Employees | 0 | — |
Legal name
San Serum AB
Org number
5590707971
Legal form
Aktiebolag
NACE code
6220 · Computer consultancy and computer facilities management activities
Founded
18 juli 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
San Serum AB skall bedriva konsultverksamhet rörande informationsteknologi, såsom affärs- och verksamhetsutveckling, produktutveckling, projektledning, systemutveckling, utredning och utbildning. Utöver det skall bolaget också bedriva konsultverksamhet inom reklam- och marknadsföring, såsom reklamframställning, grafiska tjänster och internetmarknadsföring. Bolaget skall utveckla produkter, applikationer och tjänster inom mobilitet. Bolaget skall också äga och förvalta fast och lös egendom samt bedriva därmed förenlig verksamhet.
Address
Lillgatan 14
Email
melin.staffan@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 747 | 1 793 | 2 081 | 2 117 | 2 137 |
| Staff expenses | — | — | −929 | −1 051 | −1 263 |
| EBITDA | 653 | 651 | 808 | 643 | 439 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 653 | 651 | 808 | 643 | 439 |
| Net financials | 21 | 17 | −1 | — | — |
| Profit before tax | 674 | 634 | 807 | 643 | 439 |
| Tax | −150 | −134 | −170 | −136 | −95 |
| Net profit | 524 | 500 | 637 | 506 | 345 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 428 | 1 910 | 2 264 | 2 514 | 2 813 |
| Equity | 1 356 | 1 672 | 2 032 | 2 232 | 2 237 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 72 | 239 | 232 | 282 | 286 |
| Total debt | 72 | 239 | 232 | 282 | 286 |
EBITDA margin
20.6%
This company
15.8%
Market median
+30% vs market
20202024
Equity ratio
79.5%
This company
38.2%
Market median
+108% vs market
20202024
Return on equity
15.4%
This company
18.4%
Market median
+16% vs market
20202024
Net profit margin
16.1%
This company
8.1%
Market median
+99% vs market
20202024
Asset turnover
0.76×
This company
1.12×
Market median
-32% vs market
20202024
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of San Serum AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Staffan Johan Melin | Chairman | 0 companies |
| Ulrica Melin | Board of Directors | 0 companies |
| Kurt Ingvar Hilding Melin | Deputy Board Member | 0 companies |